Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $7.87M.
ENTERPRISE VALUE (EV)
$7.87M
Gelteq Limited Ordinary Shares
Market Cap
$5.32M
Enterprise Value (EV)
$7.87M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Gelteq Limited Ordinary Shares (GELS) | $5.32M | $7.87M |
| Alzamend Neuro Inc (ALZN)vs › | $5.29M | N/A |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.24M | $3.07M |
| Pulmatrix, Inc. (PULM)vs › | $5.22M | $3.05M |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.21M | $3.64M |
| Lunai Bioworks Inc. (LNAI)vs › | $5.19M | $3.45M |
| Imunon, Inc. (IMNN)vs › | $5.08M | $6.07M |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.59M | N/A |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.01M | $11.64M |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $5.69M | $3.64M |
Market Cap
$5.32M
Total Debt
$2.77M
Cash
$226747.37
Enterprise Value
$7.87M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
